Associated Papers
Peripheral expression of dopamine genes as a biomarker for cocaine addiction in humans.
Kigar S et al.
European Addiction Research, 2026
Opposite effects of DRD2 gene polymorphisms on inhibitory control and motor output in antisaccade task in healthy subjects and schizophrenia patients.
Kirenskaya AV et al.
Molecular Biology Reports, 2026
Genetics of Response to ECT, TMS, Ketamine and Esketamine.
Franklin CE et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2025
Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis".
Blum K et al.
Acta Scientific Neurology, 2025
The minor allele of the serotonin transporter gene variant rs4251417 is associated with increased resilience in soldiers experiencing acute stress during survival training: preliminary findings.
Petrovick M et al.
Anxiety, Stress, and Coping, 2025
Lifespan longitudinal changes in mesocortical thickness and executive function: Role of dopaminergic genetic predisposition.
Miranda GG et al.
Neurobiology of Aging, 2025
Working memory gating in obesity is moderated by striatal dopaminergic gene variants.
Herzog N et al.
Elife, 2024
Gene-gene and gene-environmental interaction of dopaminergic system genes in Pakistani children with attention deficit hyperactivity disorder.
Ansari MA et al.
Saudi Journal of Biological Sciences, 2024
The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms.
Papenberg G et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 2024
The association of genetic polymorphisms within the dopaminergic system with nicotine dependence: A narrative review.
Yang J et al.
Heliyon, 2024
Prominent genetic variants and epigenetic changes in post-traumatic stress disorder among combat veterans.
Baghaei A et al.
Molecular Biology Reports, 2024
Analysis of Dopamine Receptor D2 Gene Polymorphism and Correlation with Dyslipidemia in the Chinese Population.
Tan H et al.
Molecular Syndromology, 2024
Genetic Aspects of Problematic and Risky Internet Use in Young Men-Analysis of ANKK1, DRD2 and NTRK3 Gene Polymorphism.
Rył A et al.
Genes, 2024
Molecular Mechanisms and the Significance of Synonymous Mutations.
Oelschlaeger P
Biomolecules, 2024
Genetic variation in the dopamine system is associated with mixed-strategy decision-making in patients with Parkinson's disease.
Parr AC et al.
The European Journal of Neuroscience, 2023
Genetic contributions to brain serotonin transporter levels in healthy adults.
Bruzzone SEP et al.
Scientific Reports, 2023
In silico methods for predicting functional synonymous variants.
Lin BC et al.
Genome Biology, 2023
Assessment of genetic variants in D2 dopamine receptor (DRD2) gene as risk factors for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD): A systematic review and meta-analysis.
Zhang X et al.
Journal of Affective Disorders, 2023
Hippocampal and motor regions contribute to memory benefits after enacted encoding: cross-sectional and longitudinal evidence.
Noroozian M et al.
Cerebral Cortex (new York, N.y. : 1991), 2023
Genotype-by-diagnosis interaction influences self-control in human cocaine addiction.
Graczyk MM et al.
Translational Psychiatry, 2023
Antipsychotic drug-aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms.
Stelmach A et al.
Pharmacological Reports : Pr, 2023
Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine.
De Pieri M et al.
Frontiers in Pharmacology, 2023
DRDs and Brain-Derived Neurotrophic Factor Share a Common Therapeutic Ground: A Novel Bioinformatic Approach Sheds New Light Toward Pharmacological Treatment of Cognitive and Behavioral Disorders.
Papageorgiou L et al.
Advances in Experimental Medicine and Biology, 2023
Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Płaza O et al.
Biomedicines, 2022
The effects of catechol-O-methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta-analysis.
Misir E et al.
Psych Journal, 2022
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing.
Modestino EJ et al.
Journal of Personalized Medicine, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
Dennen CA et al.
Journal of Personalized Medicine, 2022
Inverse Salt Sensitivity of Blood Pressure Is Associated with an Increased Renin-Angiotensin System Activity.
Gildea JJ et al.
Biomedicines, 2022
Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the DRD2 Gene with Neuroticism in Patients with Substance Use Disorder.
Boroń A et al.
International Journal of Environmental Research and Public Health, 2022
Folate Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with Alzheimer's Disease with a Change in Metabolic Profile.
Miyan J et al.
Metabolites, 2022
Dopamine-related polymorphisms and Affective Working Memory in aging.
Fairfield B et al.
Neurobiology of Learning and Memory, 2022
Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders.
Śmiarowska M et al.
International Journal of Environmental Research and Public Health, 2022
Interaction Effects of DRD2 Genetic Polymorphism and Interpersonal Stress on Problematic Gaming in College Students.
Kim E et al.
Genes, 2022
Functionally Antagonistic Transcription Factors IRF1 and IRF2 Regulate the Transcription of the Dopamine Receptor D2 Gene Associated with Aggressive Behavior of Weaned Pigs.
Zhao J et al.
Biology, 2022
Fatigue in breast cancer patients on chemotherapy: a cross-sectional study exploring clinical, biological, and genetic factors.
Hajj A et al.
Bmc Cancer, 2022
Effects of OPRM1 and DRD2 on brain structure in drug-naïve adolescents: Genetic and neural vulnerabilities to substance use.
Picci G et al.
Psychopharmacology, 2022
Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population.
Ceccarini MR et al.
Frontiers in Nutrition, 2022
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF et al.
Frontiers in Pharmacology, 2022
A common polymorphism in the dopamine transporter gene predicts working memory performance and in vivo dopamine integrity in aging.
Karalija N et al.
Neuroimage, 2021
Motivational learning biases are differentially modulated by genetic determinants of striatal and prefrontal dopamine function.
Richter A et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2021
Genetics and Cognitive Vulnerability to Sleep Deprivation in Healthy Subjects: Interaction of ADORA2A, TNF-α and COMT Polymorphisms.
Erblang M et al.
Life (basel, Switzerland), 2021
Reviewing pharmacogenetics to advance precision medicine for opioids.
Magarbeh L et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2021
Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.
Hajj A et al.
Bmc Cancer, 2021
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside.
Shad MU
Behavioral Sciences (basel, Switzerland), 2021
Genetic Influences on Patient-Oriented Outcomes in Traumatic Brain Injury: A Living Systematic Review of Non-Apolipoprotein E Single-Nucleotide Polymorphisms.
Zeiler FA et al.
Journal of Neurotrauma, 2021
Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.
Magistrelli L et al.
International Journal of Molecular Sciences, 2021
Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population.
Gaither JBS et al.
Gigascience, 2021